Zygomycosis in neutropenic patients with past Aspergillus infection: a role for posaconazole?

Recommendation for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995; 16: 105–113. 5. Chia JKS, Nakata MM, Park SS, Lewis RP, McKee B. Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium. Clin Infect Dis 1995; 21: 1520. 6. Whitman MS, Pitsakis PG, DeJesus E, Osborne AJ, Levison ME, Johnson CC. Gastrointestinal tract colonisation with vancomycin-resistant Enterococcus faecium in an animal model. Antimicrob Agents Chemother 1996; 40: 1526–1530. 7. Anonymous. European Antimicrobial Resistance Surveillance System Newsletter. Bilthoven, The Netherlands: National Institute of Public Health and the Environment, 2002. 8. Bonten JM, Willems R, Weinstein RA. Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect Dis 2001; 1: 314–325.